Luye Pharma Announces U.S. Launch of ERZOFRI® (paliperidone palmitate) Extended-Release Injectable Suspension for the Treatment of Schizophrenia and Schizoaffective Disorder
Telix Appoints Paul Schaffer as Chief Technology Officer
QC Ware Announces 4th Q2B Tokyo Conference Focused on the Roadmap to Quantum Value in Asia and Beyond, Quemix to Co-host and Sponsor
Trip.com Kicks Off Mega Sale on Flights & Hotels to Celebrate Easter
Advancing Circular Economy: Sorbent Tissues Drive Sustainable Solutions in Australia
TheLotter Australia: Exciting Changes to the US Mega Millions This Week
/R E P E A T — MEDIA ADVISORY – Canada's No. 1 Hospital to announce strategy to attract world's most promising scientists to drive health innovation and economic growth/
The Phase III Study Data of Stapokibart for Seasonal Allergic Rhinitis Published in Nature Medicine
